|502.23||+4.14||+0.83%||Vol 2.69M||1Y Perf 20.54%|
|May 26th, 2022 16:00 DELAYED|
|- -||-2.34 -0.47%|
|Target Price||565.17||Analyst Rating||Strong Buy 1.34|
|Potential %||12.53||Finscreener Ranking||★+ 43.73|
|Insiders Trans % 3/6/12 mo.||-100/-78/-93||Value Ranking||★+ 42.63|
|Insiders Value % 3/6/12 mo.||-100/-86/-99||Growth Ranking||★★★+ 54.09|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-85/-99||Income Ranking||★★ 38.65|
|Price Range Ratio 52W %||69.99||Earnings Rating||Sell|
|Market Cap||471.18B||Earnings Date||15th Jul 2022|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||15th Jul 2022|
|Estimated EPS Next Report||5.25|
|EPS Growth Next 5 Years %||14.80|
|Avg. Weekly Volume||2.85M|
|Avg. Monthly Volume||3.04M|
|Avg. Quarterly Volume||3.09M|
UnitedHealth Group Incorporated (DE) (NYSE: UNH) stock closed at 502.23 per share at the end of the most recent trading day (a 0.83% change compared to the prior day closing price) with a volume of 2.69M shares and market capitalization of 471.18B. Is a component of S&P 500, Dow Jones 30, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 330000 people. UnitedHealth Group Incorporated (DE) CEO is Andrew P. Witty.
The one-year performance of UnitedHealth Group Incorporated (DE) stock is 20.54%, while year-to-date (YTD) performance is 0.02%. UNH stock has a five-year performance of 182.95%. Its 52-week range is between 383.12 and 553.29, which gives UNH stock a 52-week price range ratio of 69.99%
UnitedHealth Group Incorporated (DE) currently has a PE ratio of 26.60, a price-to-book (PB) ratio of 6.26, a price-to-sale (PS) ratio of 1.56, a price to cashflow ratio of 21.40, a PEG ratio of 2.32, a ROA of 8.49%, a ROC of 16.14% and a ROE of 25.99%. The company’s profit margin is 6.08%, its EBITDA margin is 9.20%, and its revenue ttm is $295.31 Billion , which makes it $314.77 revenue per share.
Of the last four earnings reports from UnitedHealth Group Incorporated (DE), there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $5.25 for the next earnings report. UnitedHealth Group Incorporated (DE)’s next earnings report date is 15th Jul 2022.
The consensus rating of Wall Street analysts for UnitedHealth Group Incorporated (DE) is Strong Buy (1.34), with a target price of $565.17, which is +12.53% compared to the current price. The earnings rating for UnitedHealth Group Incorporated (DE) stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
UnitedHealth Group Incorporated (DE) has a dividend yield of 1.18% with a dividend per share of $5.80 and a payout ratio of 34.00%.
UnitedHealth Group Incorporated (DE) has a Buy technical analysis rating based on Technical Indicators (ADX : 7.98, ATR14 : 13.60, CCI20 : 31.63, Chaikin Money Flow : 0.07, MACD : -5.99, Money Flow Index : 50.10, ROC : 2.40, RSI : 50.26, STOCH (14,3) : 89.17, STOCH RSI : 1.00, UO : 57.08, Williams %R : -10.83), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of UnitedHealth Group Incorporated (DE) in the last 12-months were: Andrew P. Witty (Sold 6 000 shares of value $2 484 900 ), John F. Rex (Option Excercise at a value of $3 039 533), John F. Rex (Sold 15 438 shares of value $6 361 027 ), Paul R. Garcia (Buy at a value of $997 817), Richard T. Burke (Sold 71 500 shares of value $31 703 854 ), Stephen J. Hemsley (Sold 255 000 shares of value $111 510 594 )
Wed, 11 May 2022 21:01 GMT UnitedHealth Stock: Analysts See 21% Upside Potential- TipRanks. All rights reserved.
Tue, 19 Apr 2022 08:31 GMT Leerink Partners Believes UnitedHealth (UNH) Still Has Room to Grow- TipRanks. All rights reserved.
Fri, 15 Apr 2022 00:45 GMT Bank of America Securities Believes UnitedHealth (UNH) Wont Stop Here- TipRanks. All rights reserved.
Thu, 31 Mar 2022 07:05 GMT Analysts Are Bullish on These Healthcare Stocks: UnitedHealth (UNH), Aldeyra Therapeutics (ALDX)- TipRanks. All rights reserved.
Wed, 30 Mar 2022 07:24 GMT UnitedHealth Acquires LHC Group to Pursue $226B Market- TipRanks. All rights reserved.
Mon, 07 Mar 2022 16:03 GMT United Health Stock: Hedge Funds Turn Bearish- TipRanks. All rights reserved.
Sun, 06 Mar 2022 16:35 GMT Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH) and Axsome Therapeutics (AXSM)- TipRanks. All rights reserved.
Thu, 17 Feb 2022 11:19 GMT Inside UnitedHealths Risk Factors- TipRanks. All rights reserved.
Fri, 04 Feb 2022 00:31 GMT UnitedHealth Group: Consistent Growth and Profitability- TipRanks. All rights reserved.
Thu, 20 Jan 2022 08:37 GMT UnitedHealth (UNH) Gets a Buy Rating from Evercore ISI- TipRanks. All rights reserved.
Fri, 14 Jan 2022 02:06 GMT UnitedHealth (UNH) Receives a Buy from RBC Capital- TipRanks. All rights reserved.
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.